| Active substance |
FTTP |
| Also known as |
FTPP (Fat Targeted Proapoptotic Peptide) |
| Blood pressure |
Can cause alterations in blood pressure, monitoring advised |
| Chemical name |
CKGGRAKDC-GG- D(KLAKLAK)2 |
| Dosage (medical) |
Generally, initial doses used in studies were around 0.43 mg/kg/day |
| Dosage (sports) |
Not applicable, as it is not typically used for athletic enhancement |
| Effects |
Promotes weight loss by targeting and killing vascular cells in adipose tissue |
| Formula |
C111H204N36O28S2 |
| Half-life |
Approximately 30 hours |
| Hepatotoxicity |
No significant hepatotoxicity reported in studies |
| Lab Test |
Specific tests for adipotide are not commonly available in standard medical settings |
| Main action |
Induces apoptosis in blood vessels supplying adipose tissue |
| Side effects |
Potential renal toxicity, dehydration, alterations in blood pressure |
| Storage conditions |
Store in a cool, dry place, away from light, typically at 2-8В°C |
| Substance class |
Peptide |
| Trade name |
Not commercially available under any trade name as of last reports |
| Use in sports |
Not commonly used in sports due to its specific mechanism targeting fat loss and potential health risks |
| WAREHOUSE |
International Warehouse 3 |
| Water Retention |
No significant water retention reported |
| Manufacturer |
Ultima Peptides |
